- Release Date: 20/07/22 09:29
- Summary: CCR Q4FY22 ACTIVITY REPORT AND APPENDIX 4C
- Price Sensitive: Yes
- Download Document 659.43KB
- Forums
- ASX - By Stock
- CCR
- Ann: CCR Q4FY22 ACTIVITY REPORT AND APPENDIX 4C
CCR
credit clear limited
Add to My Watchlist
2.13%
!
24.0¢

Ann: CCR Q4FY22 ACTIVITY REPORT AND APPENDIX 4C
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.0¢ |
Change
0.005(2.13%) |
Mkt cap ! $101.9M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 22.5¢ | $89.04K | 383.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4109 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4109 | 0.235 |
1 | 64363 | 0.230 |
2 | 70624 | 0.225 |
1 | 100000 | 0.215 |
2 | 87609 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 100000 | 1 |
0.260 | 29454 | 1 |
0.275 | 29999 | 1 |
0.280 | 29083 | 1 |
0.300 | 3600 | 1 |
Last trade - 15.59pm 04/07/2025 (20 minute delay) ? |
Featured News
CCR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online